Table 1.

Frequency of somatic abnormalities in black South African patients homozygous for the FANCG deletion (c.637-643delTACCGCC) compared with FA patients in the European study


Site of abnormality

South African FANCG del, %

European FA-G, % (P)

European all FA, % (P)
Skin   85   70   70.4  
Radial ray   85   50 (.04)*  46.9 (.002)* 
Growth retardation   90   75   58.0 (.01)* 
Kidney   15   20   21.6  
Urogenital   5   5   11.6  
Cardiac   10   5   9.5  
Gastrointestinal   0   15   12.9  
CNS   0   0   4.6  
Deafness   5   5   10.3  
Eye
 
85
 
65
 
55.3 (.002)*
 

Site of abnormality

South African FANCG del, %

European FA-G, % (P)

European all FA, % (P)
Skin   85   70   70.4  
Radial ray   85   50 (.04)*  46.9 (.002)* 
Growth retardation   90   75   58.0 (.01)* 
Kidney   15   20   21.6  
Urogenital   5   5   11.6  
Cardiac   10   5   9.5  
Gastrointestinal   0   15   12.9  
CNS   0   0   4.6  
Deafness   5   5   10.3  
Eye
 
85
 
65
 
55.3 (.002)*
 

For South African FANCG del, n = 20; for European FA-G, n = 20; and for European all FA, n = 241.

CNS indicates central nervous system.

*

South African FA-G patients were compared with FA-G patients in the European study using Fisher exact test, and with all FA patients in the European study using the χ2 test

Close Modal

or Create an Account

Close Modal
Close Modal